RiOSM

Treatment and Research for Metabolic Health

Metabolic health is a key concept that represents the well-being of the balance between blood glucose, cholesterol, blood pressure, hepatic metabolism, and body weight. Maintaining this balance is fundamental to reducing the risk of serious consequences such as diabetes, hypertension, hepatic steatosis, stroke, and heart attack, and to promote healthy aging. RiOSM is committed to countering these risks and researching innovative solutions, offering effective, personalized pathways based on clinical data.

Who it is For

The center is dedicated to people living with overweight or obesity, those presenting signs of Metabolic Syndrome, those in the pre-diabetes phase or suffering from fatty liver (non-alcoholic hepatic steatosis). Those who have multiple cardiovascular risk factors, such as high cholesterol or blood pressure levels, or a family history of these pathologies, can also benefit from the Center’s programs.

From Diagnostic Assessment to Therapeutic Plan

Each RiOSM pathway begins with a multidisciplinary visit, where specialist physicians and nutritionists take the time to gather information about the patient’s clinical history, lifestyle, nutrition, and examinations. Then we proceed with:

• Specific diagnostic examinations (such as metabolic profile, ultrasounds, fibroscan, etc.);
• A personalized therapeutic plan that combines dietary modifications, physical activity and, if necessary, innovative medications;
• Constant monitoring, with scheduled check-ups also remotely: the patient is always followed, monitored and supported.

Therapeutic Innovations: GLP-1, GIP and Bariatric Surgery

Thanks to advances in the pharmaceutical field, RiOSM has access to medications such as GLP-1 RA (for example, Semaglutide) and GIP, which can lead to weight reduction of up to 25%, improving insulin sensitivity and protecting heart health. For cases of severe obesity, where metabolic risks are high, the Center also offers bariatric surgery, with now standardized and safe procedures, such as bypass or sleeve gastrectomy, which rapidly improve metabolic health parameters.

Fatty Liver and Hepatic Health

Often overlooked, fatty liver is a clear signal of metabolic imbalance: in 25-40% of the adult population it can evolve into MASH (steato-hepatitis), increasing the risk of cirrhosis and liver cancer. RiOSM uses non-invasive examinations (such as FIB-4, elastosonography and MRI) to identify potential damage early and direct the patient toward personalized lifestyle and therapy interventions.